公司资料
MANGOCEUTICALS 股价、新闻与催化剂
- 股票代码:
- MGRX
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
0.38 USD (-9.22%)
收盘价
最后更新: 2026年8月24日
6.58M USD
市值
股价为何变动
As of Aug 24, 2026, MGRX closed down 9.22% at $0.3831. No new same-company headline was identified in the current news window.
公司概览
业务概览
Mangoceuticals is a consumer-facing healthcare company focused on men’s health, telehealth, and branded wellness products. Its story is centered on direct-to-consumer distribution rather than classic biotech innovation.
所在地与行业分类
Mangoceuticals is headquartered in the United States and listed on NASDAQ. It sits in consumer health and telehealth rather than biotechnology.
商业模式特征
The business model depends on brand building, digital acquisition, and consumer demand for health and wellness products. Investors watch user growth, gross margin, and whether the company can build a sustainable consumer franchise.
生物医药行业定位
Mangoceuticals is outside biotech and belongs in the consumer health / digital health bucket. Its stock is driven more by brand execution and customer acquisition than by drug catalysts.
未来催化剂
- Mangoceuticals’ catalysts are its men’s-health products, consumer marketing, and any update that shows the brand can keep growing. The story is mainly a consumer-demand one.
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。